Cytokinetics (CYTK) News
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.91+0.90 (+1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CYTK news summary
We found 1 recent headline mentioning Cytokinetics (CYTK): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, CYTK is up 1.45% at $62.91. The most recent story, "Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?", was published by Nasdaq on Oct 2, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology